Homeperf
Who owns Homeperf?
Homeperf is a French Healthcare company, now owned by Sapio, which acquired it in 2022 from Parquest Capital.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Fully exited in 2022 to Sapio.
- ·Average hold across 3 realized cycles: 6 years.
Ownership history
3 ownership periods · co-invest detected
Creadev International sold Homeperf to Parquest Capital, Arkea, BNP Developpement and Vivalto in 2015 after 6 years.
Parquest Capital sold Homeperf to Sapio in 2022 after 7 years.
Arkea Capital sold Homeperf to Sapio in 2020 after 4 years.
More from Parquest Capital 1
Other portfolio companies in the same fund.
France· 2016France· 2016
France· 2015
France· 2015France· 2009France· 2007More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
US
Questions
Who owns Homeperf?
Homeperf is now owned by Sapio, which acquired it in 2022 from Parquest Capital.
When did Sapio acquire Homeperf?
Sapio acquired Homeperf in 2022, buying from Parquest Capital.
Who did Homeperf sell to?
Parquest Capital sold Homeperf to Sapio in 2022 (Secondary). Arkea Capital sold Homeperf to Sapio in 2020 (Trade Sale). Creadev International sold Homeperf to Parquest Capital, Arkea, BNP Developpement and Vivalto in 2015 (Trade Sale).
Who has owned Homeperf over time?
Homeperf has been through 3 private-equity ownership periods: Creadev International · via Creadev · 2009–2015 · sold to Parquest Capital, Arkea, BNP Developpement and Vivalto · (Trade Sale); Parquest Capital · via Parquest Capital 1 · 2015–2022 · sold to Sapio · (Secondary); Arkea Capital · via Arkea Capital Investissement · 2016–2020 · sold to Sapio · (Trade Sale).